BIOINN - Biomedical Innovation Unit
CIEMAT's Biomedical Innovation Unit is focused on the development of translational
research to improve the diagnosis and treatment of inherited and acquired
pathologies through modern techniques of genetics, molecular and cellular biology
Hematopoietic Innovative
Therapies
Cell Technology
Epithelial Biomedicine
Molecular and Translational
Oncology
A gene therapy clinical trial for patients with Fanconi anemia offers its first successful results
Good preliminary clinical results of the first patient with pyruvate kinase deficiency treated with gene therapy
Gene editing for bullous epidermolysis: closer to the clinic
Development of two lung cancer models with poor prognosis and few therapeutic options
